Cargando…

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection

We described short-term HIV tropism changes occurring in peripheral blood mononuclear cells and the correlations with HIV DNA value in HIV-HCV co-infected patients cured for HCV disease and with undetectable HIV viremia or residual viremia (RV). Plasma HIV RNA, cellular HIV DNA and tropism were eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Basso, Monica, Zago, Daniela, Scaggiante, Renzo, Cavinato, Silvia, Pozzetto, Irene, Stagni, Camilla, Parisatto, Beatrice, Cattelan, Anna Maria, Battagin, Giuliana, Sarmati, Loredana, Parisi, Saverio Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085114/ https://www.ncbi.nlm.nih.gov/pubmed/33927306 http://dx.doi.org/10.1038/s41598-021-88811-6

Ejemplares similares

Sustained virological response after treatment with direct‐acting antivirals can help immune reconstitution in HIV‐HCV coinfected patients even in case of persistent HIV low‐level viremia
por: Basso, Monica, et al.
Publicado: (2020)

2506. Trends of Transmitted Resistance Mutations to Four Drug Classes, HIV-Subtypes And Herpesviruses Replication Among Subjects Recently Diagnosed as HIV Infected Over 2004–2019
por: Basso, Monica, et al.
Publicado: (2019)

Liver stiffness is not associated with short- and long-term plasma HIV RNA replication in immunocompetent patients with HIV infection and with HIV/HCV coinfection
por: Parisi, Saverio Giuseppe, et al.
Publicado: (2017)

HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV-HCV co-infected patients: a 3-years follow-up study
por: Basso, Monica, et al.
Publicado: (2014)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

HBcAb Positivity Is a Risk Factor for an Increased Detectability of HIV RNA after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Analysis of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2021)

Role of HBcAb Positivity in Increase of HIV-RNA Detectability after Switching to a Two-Drug Regimen Lamivudine-Based (2DR-3TC-Based) Treatment: Months 48 Results of a Multicenter Italian Cohort
por: Malagnino, Vincenzo, et al.
Publicado: (2023)

Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study
por: Basso, Monica, et al.
Publicado: (2018)

HIV-1 Tropism and Liver Fibrosis in HIV–HCV Co-Infected Patients
por: Abravanel, Florence, et al.
Publicado: (2012)

Oral and anal high-risk human papilloma virus infection in HIV-positive men who have sex with men over a 24-month longitudinal study: complexity and vaccine implications
por: Parisi, Saverio Giuseppe, et al.
Publicado: (2019)

Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Predicting Factors of Plasma HIV RNA Undetectability after Switching to Co-Formulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Experienced HIV-1 Patients: A Multicenter Study
por: Basso, Monica, et al.
Publicado: (2023)

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014)

Complementary Role of HCV and HIV in T-Cell Activation and Exhaustion in HIV/HCV Coinfection
por: Feuth, Thijs, et al.
Publicado: (2013)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
por: Tripathi, Gaurav, et al.
Publicado: (2022)

Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection
por: Pinchera, Biagio, et al.
Publicado: (2023)

645 Structural Bone Deficits in HIV/HCV, HCV-Monoinfected, and HIV-Monoinfected Women
por: Lo Re, Vincent, et al.
Publicado: (2014)

Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach
por: Mengoli, Carlo, et al.
Publicado: (2019)

356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment
por: Michienzi, Sarah M, et al.
Publicado: (2019)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)

Diversity and Evolution of HIV and HCV
por: Martinez, Miguel Angel
Publicado: (2021)

A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects
por: Parisi, Saverio Giuseppe, et al.
Publicado: (2013)

Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients
por: Long, Lu, et al.
Publicado: (2014)

HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective
por: Sarmati, Loredana, et al.
Publicado: (2015)

Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection
por: Xiao, Hong, et al.
Publicado: (2019)

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
por: Patel, Sonia Vibhakar, et al.
Publicado: (2020)

A retrospective study to find the prevalence of HIV, HCV and dual HIV-HCV infection in the prison inmates
por: Singh, Gur Parkash, et al.
Publicado: (2022)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

Relationship of TRIM5 and TRIM22 polymorphisms with liver disease and HCV clearance after antiviral therapy in HIV/HCV coinfected patients
por: Medrano, Luz M., et al.
Publicado: (2016)

Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
por: Lapa, Daniele, et al.
Publicado: (2021)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

Evaluation of Simplified HCV Diagnostics in HIV/HCV Co-Infected Patients in Myanmar
por: Nyein, Phyo Pyae, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_22ehe45q6d4rsm2e7c0r7958jp